10,000+ stock pitches from top investors available on joinyellowbrick.com
RA CAPITAL MANAGEMENT, L.P. 13F Holdings
Holdings from the most recent 13F from RA CAPITAL MANAGEMENT, L.P.
Filed: 2021-02-16 (Q4 2020) | Holdings: 82 | Value: $7.2B | Filing Link
PREMIUM
Author Returns
Returns are calculated from when the filing is published and are weighted by the size of the holding.
Upgrade to Yellowbrick Premium to unlock investor returns. Upgrade to Yellowbrick Premium
Filing Returns
Returns are calculated from when the filing is published and are weighted by the size of the holding.
Upgrade to Yellowbrick Premium to unlock investor returns. Upgrade to Yellowbrick Premium
Holding Returns | |||||||
|---|---|---|---|---|---|---|---|
| Stock | Put/Call | Change | Holding Pct | Value | Current Return | 3M Return | 1Y Return |
| ASND - ASCENDIS PHARMA A S | Reduce 1% $(7.4M) | 13.67% | $978.2M | +10.61% | -15.51% | -28.52% | |
| TGTX - TG THERAPEUTICS INC | Reduce 2% $(7.3M) | 6.32% | $451.8M | -15.54% | -27.25% | -76.72% | |
| NVAX - NOVAVAX INC | Add 216% ($288.8M) | 5.91% | $422.5M | -97.20% | -43.76% | -66.52% | |
| NKTX - NKARTA INC | 4.82% | $344.5M | -96.72% | -48.96% | -82.59% | ||
| FMTX - FORMA THERAPEUTICS HLDGS INC | 4.40% | $314.5M | -32.39% | -73.04% | |||
| ARVN - ARVINAS INC | 4.36% | $311.9M | -91.28% | -15.29% | -12.60% | ||
| CCXI - CHEMOCENTRYX INC | Reduce 1% $(3.1M) | 4.13% | $295.8M | -83.55% | -49.43% | ||
| AVIR - ATEA PHARMACEUTICALS INC | New Purchase | 3.14% | $224.3M | -96.15% | -71.60% | -92.68% | |
| ITOS - ITEOS THERAPEUTICS INC | 2.09% | $149.4M | -72.49% | -32.61% | -9.89% | ||
| KNTE - KINNATE BIOPHARMA INC | New Purchase | 2.00% | $142.9M | -33.57% | -73.57% | ||
| AXSM - AXSOME THERAPEUTICS INC | Reduce 19% $(30.9M) | 1.89% | $134.9M | +49.66% | -20.26% | -58.87% | |
| KROS - KEROS THERAPEUTICS INC | 1.85% | $132.3M | -74.80% | -15.08% | -13.18% | ||
| PHAT - PHATHOM PHARMACEUTICALS INC | 1.78% | $127.1M | -89.51% | -25.10% | -58.46% | ||
| RYTM - RHYTHM PHARMACEUTICALS INC | Reduce 19% $(28.6M) | 1.74% | $124.2M | +128.05% | -22.83% | -73.47% | |
| TVTX - TRAVERE THERAPEUTICS INC | New Purchase | 1.74% | $124.2M | -46.18% | -32.18% | +3.11% | |
| IMGN - IMMUNOGEN INC | Add 162% ($73.4M) | 1.66% | $118.8M | -25.03% | -40.34% | ||
| RCKT - ROCKET PHARMACEUTICALS INC COM | New Purchase | 1.64% | $117.1M | -94.97% | -26.59% | -65.44% | |
| ETNB - 89BIO INC | 1.61% | $115.4M | -57.87% | -7.99% | -81.22% | ||
| ZGNX - ZOGENIX INC | Reduce 3% $(2.9M) | 1.49% | $106.9M | -15.13% | +16.79% | ||
| PMVP - PMV PHARMACEUTICALS INC | 1.47% | $105.2M | -97.46% | -12.70% | -58.07% | ||
| OLMA - OLEMA PHARMACEUTICALS INC | New Purchase | 1.45% | $103.4M | -91.64% | -52.46% | -90.48% | |
| ADVM - ADVERUM BIOTECHNOLOGIES INC | Add 1% ($992.1K) | 1.44% | $103.0M | -98.18% | -73.02% | -89.68% | |
| MGNX - MACROGENICS INC | 1.40% | $100.0M | -92.65% | +53.50% | -46.86% | ||
| PCVX - VAXCYTE INC | Reduce 30% $(41.8M) | 1.38% | $98.6M | +29.37% | -28.85% | -23.35% | |
| IGMS - IGM BIOSCIENCES INC | 1.21% | $86.8M | -98.73% | -30.13% | -83.32% | ||
| BDTX - BLACK DIAMOND THERAPEUTICS INC | 1.16% | $83.0M | -90.76% | -7.05% | -86.31% | ||
| SPRY - SILVERBACK THERAPEUTICS INC | New Purchase | 1.13% | $80.7M | ||||
| TRIL - TRILLIUM THERAPEUTICS INC | Reduce 14% $(12.8M) | 1.09% | $77.8M | -34.43% | |||
| SLDB - SOLID BIOSCIENCES INC | New Purchase | 1.06% | $75.6M | -96.07% | -50.76% | -86.13% | |
| KALA - KALA PHARMACEUTICALS INC | 1.03% | $73.7M | -99.09% | -41.50% | -92.14% | ||
| FPRX - FIVE PRIME THERAPEUTICS INC | New Purchase | 1.02% | $72.9M | ||||
| INBX - INHIBRX INC | 0.98% | $70.2M | |||||
| LEGN - LEGEND BIOTECH CORP | 0.95% | $67.8M | +24.33% | +22.04% | +52.25% | ||
| CRIS - CURIS INC | New Purchase | 0.88% | $63.1M | -98.85% | +45.41% | -68.31% | |
| WVE - WAVE LIFE SCIENCES LTD | 0.86% | $61.2M | -35.78% | -41.01% | -71.46% | ||
| CRDF - CARDIFF ONCOLOGY INC | 0.83% | $59.2M | -72.02% | -34.69% | -77.35% | ||
| DYN - DYNE THERAPEUTICS INC | 0.82% | $58.9M | -24.01% | -2.34% | -59.70% | ||
| CNST - CONSTELLATION PHARMCETICLS INC | New Purchase | 0.75% | $53.4M | -42.39% | |||
| PACB - PACIFIC BIOSCIENCES OF CALIFORNIA INC | New Purchase | 0.72% | $51.6M | -97.80% | -48.55% | -75.74% | |
| GERN - GERON CORP | 0.67% | $47.9M | -17.89% | -24.74% | -45.79% | ||
| STRO - SUTRO BIOPHARMA INC | 0.64% | $46.0M | -96.50% | -15.93% | -63.04% | ||
| CCCC - C4 THERAPEUTICS INC | New Purchase | 0.64% | $45.6M | -96.42% | -15.83% | -45.79% | |
| AKUS - AKOUOS INC | 0.63% | $45.2M | -30.06% | -70.79% | |||
| RLAY - RELAY THERAPEUTICS INC | 0.58% | $41.6M | -92.70% | -31.58% | -52.64% | ||
| INZY - INOZYME PHARMA INC | 0.58% | $41.4M | -80.06% | -20.54% | -65.52% | ||
| ORTX - ORCHARD THERAPEUTICS PLC | 0.58% | $41.2M | -30.26% | -86.92% | |||
| ARDX - ARDELYX INC | Reduce 2% $(632.9K) | 0.56% | $39.9M | -50.24% | -6.63% | -90.41% | |
| CERE - CEREVEL THERAPEUTICS HLDNG INC | New Purchase | 0.51% | $36.5M | ||||
| ARQT - ARCUTIS BIOTHERAPEUTICS INC | 0.46% | $32.8M | -61.13% | -27.85% | -53.91% | ||
| LRMR - LARIMAR THERAPEUTICS INC | 0.45% | $32.4M | -86.91% | -27.30% | -79.24% | ||
| ADAP - ADAPTIMMUNE THERAPEUTICS PLC | Reduce 100% | 0.00% | $0.00 | ||||
| ALEC - ALECTOR INC | Reduce 100% | 0.00% | $0.00 | ||||
| CRNX - CRINETICS PHARMACEUTICALS INC | Reduce 100% | 0.00% | $0.00 | ||||
| EIDX - EIDOS THERAPEUTICS INC | Reduce 100% | 0.00% | $0.00 | ||||
| OCUL - OCULAR THERAPEUTIX INC | Reduce 100% | 0.00% | $0.00 | ||||
| PAND - PANDION THERAPEUTICS INC | Reduce 100% | 0.00% | $0.00 | ||||
| PRVL - PREVAIL THERAPEUTICS INC | Reduce 100% | 0.00% | $0.00 | ||||
| RLMD - RELMADA THERAPEUTICS INC | Reduce 100% | 0.00% | $0.00 | ||||
| TVTX - RETROPHIN INC | Reduce 100% | 0.00% | $0.00 | ||||
| SCPH - SCPHARMACEUTICALS INC | Reduce 100% | 0.00% | $0.00 | ||||
| MCRB - SERES THERAPEUTICS INC | Reduce 100% | 0.00% | $0.00 | ||||
| VXRT - VAXART INC | Reduce 100% | 0.00% | $0.00 | ||||
| VRNA - VERONA PHARMA PLC | Reduce 100% | 0.00% | $0.00 | ||||